CompletedPhase 4NCT00872066

A Study to Assess the Long-term Performance of SmartSet® HV and SmartSet® GHV Bone Cements in Primary Total Hip Replacement

Studying Avascular necrosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
DePuy International
Principal Investigator
Libor Nečas, M.D.
Orthopaedic-truamatology Clinic, University Hospital Martin, Slovakia
Intervention
SmartSet® HV bone cement(device)
Enrollment
243 enrolled
Eligibility
18-75 years · All sexes
Timeline
20062016

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00872066 on ClinicalTrials.gov

Other trials for Avascular necrosis

Additional recruiting or active studies for the same condition.

See all trials for Avascular necrosis

← Back to all trials